Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -13.48%438.98M | -11.10%382.19M | 7.91%487.36M | 20.43%1.92B | 29.43%517.9M | 25.75%507.39M | 10.93%429.91M | 14.42%451.63M | -32.12%1.59B | -21.38%400.15M |
| Cost of revenue | 19.75%1.14B | -31.76%950.49M | ||||||||
| Gross profit | 21.45%777.96M | -32.64%640.55M | ||||||||
| Operating expense | -15.70%393.89M | -12.16%343.67M | 7.04%439.48M | 8.37%663.56M | 32.65%478.34M | 31.86%467.24M | 1.69%391.25M | -0.66%410.59M | -20.00%612.3M | 142.21%360.59M |
| Staff costs | ---- | ---- | ---- | 4.50%312.65M | ---- | ---- | ---- | ---- | -20.11%299.18M | ---- |
| Depreciation and amortization | ---- | ---- | ---- | -5.64%102.45M | ---- | ---- | ---- | ---- | -13.31%108.57M | ---- |
| -Depreciation | ---- | ---- | ---- | -5.64%102.45M | ---- | ---- | ---- | ---- | -13.31%108.57M | ---- |
| Other operating expenses | -16.11%407.74M | -12.37%358.4M | 5.83%454.42M | 18.80%299.48M | 30.25%494.14M | 30.03%486.07M | 1.79%409.01M | -0.28%429.39M | -18.62%252.08M | 128.01%379.38M |
| Total other operating income | -26.46%13.85M | -17.06%14.73M | -20.54%14.94M | 7.31%51.01M | -15.90%15.8M | -3.32%18.83M | 3.97%17.76M | 9.05%18.8M | 7.71%47.54M | 3,170.59%18.79M |
| Operating profit | 12.28%45.09M | -0.35%38.52M | 16.66%47.88M | 304.95%114.4M | 0.00%39.56M | -18.28%40.16M | 1,286.90%38.65M | 320.33%41.04M | -84.77%28.25M | 233.94%39.56M |
| Net non-operating interest income (expenses) | 79.61%-84K | 52.50%-38K | -1,006.90%-642K | 3.12%42.92M | -10.00%-814K | -130.17%-412K | 68.87%-80K | 87.05%-58K | 43.45%41.62M | -102.30%-740K |
| Non-operating interest income | ---- | ---- | ---- | 4.32%44.89M | ---- | ---- | ---- | ---- | 29.35%43.03M | ---- |
| Non-operating interest expense | -79.61%84K | -52.50%38K | 1,006.90%642K | 39.52%1.97M | 10.00%814K | 130.17%412K | -68.87%80K | -87.05%58K | -66.81%1.41M | -33.93%740K |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 100.01%2K | 0 | -3,353.27%-35.33M | -35.38M | ||||||
| Less:Impairment of capital assets | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- | --35.38M | --35.38M |
| Less:Write off | ---- | ---- | ---- | 96.49%-2K | ---- | ---- | ---- | ---- | -105.57%-57K | ---- |
| Other non-operating income (expenses) | ||||||||||
| Income before tax | 13.23%45M | -0.24%38.48M | 15.26%47.24M | 355.45%157.32M | 1,028.28%38.75M | -18.82%39.74M | 1,424.62%38.57M | 314.85%40.98M | -83.82%34.54M | 116.25%3.43M |
| Income tax | -30.33%6.75M | 10.04%7.07M | 25.45%11.21M | 100.50%36.54M | 474.10%10.55M | 35.26%9.69M | 23.93%6.43M | 98.53%8.94M | -66.44%18.23M | -55.90%1.84M |
| Net income | 27.27%38.25M | -2.29%31.41M | 12.42%36.03M | 640.24%120.78M | 1,666.48%28.19M | -28.09%30.06M | 1,310.32%32.15M | 235.93%32.05M | -89.75%16.32M | 161.86%1.6M |
| Net income continuous operations | 27.27%38.25M | -2.29%31.41M | 12.42%36.03M | 640.24%120.78M | 1,666.48%28.19M | -28.09%30.06M | 1,310.32%32.15M | 235.93%32.05M | -89.75%16.32M | 161.86%1.6M |
| Noncontrolling interests | -31.88%421K | -68.20%256K | -36.72%374K | -18.03%2.44M | -37.72%492K | -25.09%618K | 25.39%805K | -12.96%591K | 40.72%2.98M | 347.65%790K |
| Net income attributable to the company | 28.52%37.83M | -0.60%31.15M | 13.35%35.65M | 787.27%118.34M | 3,336.85%27.7M | -28.15%29.44M | 1,050.30%31.34M | 229.69%31.45M | -91.51%13.34M | 135.65%806K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 28.52%37.83M | -0.60%31.15M | 13.35%35.65M | 787.27%118.34M | 3,336.85%27.7M | -28.15%29.44M | 1,050.30%31.34M | 229.69%31.45M | -91.51%13.34M | 135.65%806K |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 30.43%0.015 | 0.00%0.0123 | 13.82%0.014 | 792.31%0.0464 | 3,533.33%0.0109 | -28.57%0.0115 | 1,046.15%0.0123 | 229.47%0.0123 | -91.56%0.0052 | 133.33%0.0003 |
| Diluted earnings per share | 30.43%0.015 | 0.00%0.0123 | 13.82%0.014 | 792.31%0.0464 | 3,533.33%0.0109 | -28.57%0.0115 | 1,046.15%0.0123 | 229.47%0.0123 | -91.56%0.0052 | 133.33%0.0003 |
| Dividend per share | 0 | 0 | 0 | 140.00%0.06 | 0.02 | 0 | 0.02 | -20.00%0.02 | -79.17%0.025 | 0 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.